By Noah Higgins-Dunn,Kevin Dunleavy,Fraiser Kansteiner
India likely won't resume major exports of COVID-19 vaccines until October, government sources tell Reuters, a major hit to the world's poorest nations. The U.S. vaccinated roughly 600,000 adolescents with the Pfizer-BioNTech vaccine last week, the CDC director reports. And more headlines.
read more
By Annalee Armstrong
In an unprecedented public rebuke, the FDA accused CytoDyn of trying to cherry-pick data from two failed studies of leronlimab in COVID-19 patients to claim the drug is effective. Plus, a stockholder has filed a class action lawsuit alleging that CytoDyn made false and misleading statements about the viability of leronlimab in treating COVID-19, a securities filing shows.
read more
By Dave Muoio
The Illinois- and Wisconsin-based nonprofit had lost more than $1.3 billion during the same time last year. The system wrote that much of the swing was driven by the performance of its various investments.
read more
By Dave Muoio
CommonSpirit reversed last year's losses in spite of persistent low volumes and higher costs. The Catholic health system said it's still planning for "a low, but steady" stream of COVID-19 patients across its inpatient locations during the foreseeable future.
read more
By Healthcare Staff
Follow along with the latest COVID-19 news straight from the Fierce Healthcare team.
read more
.jpg)
